Azza Ramadan, Anan S Jarab, Ahmad Z Al Meslamani, Hebatallah Ahmed Mohamed Moustafa, Amira B Kassem, Abuelnor Mohammed, Wael Osman, Reem Ibrahim, Karem H Alzoubi
{"title":"Assessment of contraceptive use and side effects among women in five countries across the Middle East: a cross-sectional study.","authors":"Azza Ramadan, Anan S Jarab, Ahmad Z Al Meslamani, Hebatallah Ahmed Mohamed Moustafa, Amira B Kassem, Abuelnor Mohammed, Wael Osman, Reem Ibrahim, Karem H Alzoubi","doi":"10.1080/03007995.2025.2472907","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Contraceptive use and associated adverse effects are underreported in the Middle East. This study aimed to investigate contraceptive use and reported side effects in five Middle Eastern countries.</p><p><strong>Methods: </strong>This study, conducted over eight weeks in the UAE, Egypt, Jordan, Syria, and Iraq, utilized an online closed-ended structured questionnaire to extract the study information. Reproductive-age women were surveyed about hormonal and non-hormonal contraceptive usage practices, frequency, types, and severity of contraceptive-associated side effects. Logistic regression analysis was utilized to determine the predictors of the occurrence of side effects associated with contraceptive use.</p><p><strong>Results: </strong>The prevalence of contraceptive use was 81.2% (1069/1317). The most common contraceptive methods were combined oral contraceptive pills (46.6%, 511/1069), mini pills (15.4%, 169/1069), and hormonal loops (13.8%, 151/1069). The prevalence of contraceptive-associated side effects was 41.9% (448/1069). The commonly reported mild-to-moderate side effects were irregular menstrual bleeding (87.9%), headaches (88.2%), and mood changes (93.5%). Interestingly, the participants living in Egypt (AOR: 14.58, 95% CI: 4.67-45.53, <i>p</i> = 0.012) and Iraq (AOR: 25.71, 95% CI: 9.93-66.60, <i>p</i> = 0.001) had greater odds of developing contraceptive-related side effects than did their counterparts. Breastfeeding (AOR: 0.43, 95% CI: 0.20-0.92, <i>p</i> = 0.03), hypertension (AOR: 0.50, 95% CI: 0.26-0.99, <i>p</i> = 0.047), and smoking (AOR: 0.43, 95% CI: 0.20-0.90, <i>p</i> = 0.027) status reduced the risk of side effects. Surprisingly, healthcare follow-ups significantly increased the risk of side effects among contraceptive users (AOR: 3.48, 95% CI: 2.03-5.97; <i>p</i> = 0.001).</p><p><strong>Conclusion: </strong>Many contraceptive users reported experiencing side effects, which are predominantly mild to moderate. This underscores the need for improved patient education and follow-up, especially in Egypt and Iraq.</p>","PeriodicalId":10814,"journal":{"name":"Current Medical Research and Opinion","volume":" ","pages":"1-10"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Research and Opinion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03007995.2025.2472907","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Contraceptive use and associated adverse effects are underreported in the Middle East. This study aimed to investigate contraceptive use and reported side effects in five Middle Eastern countries.
Methods: This study, conducted over eight weeks in the UAE, Egypt, Jordan, Syria, and Iraq, utilized an online closed-ended structured questionnaire to extract the study information. Reproductive-age women were surveyed about hormonal and non-hormonal contraceptive usage practices, frequency, types, and severity of contraceptive-associated side effects. Logistic regression analysis was utilized to determine the predictors of the occurrence of side effects associated with contraceptive use.
Results: The prevalence of contraceptive use was 81.2% (1069/1317). The most common contraceptive methods were combined oral contraceptive pills (46.6%, 511/1069), mini pills (15.4%, 169/1069), and hormonal loops (13.8%, 151/1069). The prevalence of contraceptive-associated side effects was 41.9% (448/1069). The commonly reported mild-to-moderate side effects were irregular menstrual bleeding (87.9%), headaches (88.2%), and mood changes (93.5%). Interestingly, the participants living in Egypt (AOR: 14.58, 95% CI: 4.67-45.53, p = 0.012) and Iraq (AOR: 25.71, 95% CI: 9.93-66.60, p = 0.001) had greater odds of developing contraceptive-related side effects than did their counterparts. Breastfeeding (AOR: 0.43, 95% CI: 0.20-0.92, p = 0.03), hypertension (AOR: 0.50, 95% CI: 0.26-0.99, p = 0.047), and smoking (AOR: 0.43, 95% CI: 0.20-0.90, p = 0.027) status reduced the risk of side effects. Surprisingly, healthcare follow-ups significantly increased the risk of side effects among contraceptive users (AOR: 3.48, 95% CI: 2.03-5.97; p = 0.001).
Conclusion: Many contraceptive users reported experiencing side effects, which are predominantly mild to moderate. This underscores the need for improved patient education and follow-up, especially in Egypt and Iraq.
期刊介绍：
Current Medical Research and Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
